This study investigates pancreatic cancer. It evaluates the effects of an investigational medication along with Vitamin D3 in combination with chemotherapy.
The purpose of this study is to evaluate the safety and effectiveness of the investigational medication and Vitamin D3 when used with chemotherapy. It looks at how well this combination works in treating pancreatic cancer.
- Who can participate: Adults aged 18 to 75 with metastatic Stage IV pancreatic adenocarcinoma and a performance status of 0 or 1 may participate.
- Study details: Participants will receive an investigational medication, chemotherapy, and Vitamin D3. Some may receive a placebo, an inactive substance that looks like the investigational medicine but does not contain any medicine.